Lowe's Companies Inc. (LOW)

NYSE: LOW · Echtzeitkurs · USD

220.00

+4.36 (2.02%)

Zum Schluss: Aug 19, 2026, 8:04 PM

220.12

+0.05%

Nachbörslich: 6:57 PM

2.02% (1D)

Keine Daten verfügbar

Geld	221.04
Marktkapitalisierung	123.36 Mrd
Umsatz (TTM)	88.43 Mrd
Nettogewinn (TTM)	6.62 Mrd
Beta	0.85
EPS (ttm)	11.84
KGV (TTM)	18.58
Forward-KGV	16.48
KBV (TTM)	-13.31
KUV (TTM)	1.40
Earnings Date	Aug 19, 2026

Brief	220.59
Volumen	4,956,178
Ø Vol. (20D)	3,033,961
Eröffnung	217.00
Vortagesschluss	215.64
Tagesspanne	212.50 - 225.79
52-Wk Range	199.40 - 293.06
Analyst	n/a
Kursziel	n/a
Dividenden	$5 (2.32%)
Ex-Dividenden-Datum	22. Juli 2026

Über LOW

Lowe's Companies, Inc., together with its subsidiaries, operates as a home improvement retailer in the United States and Canada. It provides a line of products for construction, maintenance, repair, remodeling, and decorating. The company also offers home improvement products, such as appliances, seasonal and outdoor living, lumber, lawn and garden, kitchens and bath, hardware, building materials, millwork, paint, rough plumbing, tools, electrica...

[Mehr lesen]

Branche Home Improvement Retail

Sektor Consumer Cyclical

IPO Datum Mar 17, 1980

Mitarbeiter 167,000

Börse NYSE

Tickersymbol LOW

Website https://corporate.lowes.com

Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr 2026 betrug der Umsatz von Lowe's Companies 86.29 Mrd, ein Anstieg von 3.12% im Vergleich zum Vorjahr (83.67 Mrd). Der Gewinn lag bei 6.65 Mrd, ein Rückgang von -4.36 %.

Finanzberichte

Gewinnüberraschung

Neu

Lowe's Companies hat die Quartalszahlen am Aug 19, 2026 veröffentlicht:

Umsatz von $23.08 Mrd verfehlt die Erwartungen um $0, mit 10.26% Wachstum im Jahresvergleich.

EPS von 4.4 übertrifft die Erwartungen um 0.18, mit 1.62% Wachstum im Jahresvergleich.

Nachrichten

vor 2 Stunden · Investor's Business Daily

Dow Jones Futures: S&P 500, Nasdaq Rise On Treasury Move; Moderna, Merck Spur Big Biopharma Gains

The S&P 500 and Nasdaq rose slightly Wednesday as Treasury yields fell. Moderna and Merck fueled big gains for biotechs, drugmakers.

vor 4 Stunden · Insider Monkey

Lowe’s Companies (LOW) Shows Profit Resilience, But Housing Headwinds Persist

Lowe’s Companies, Inc. (NYSE:LOW)’s second-quarter results were a mixed bag. The company beat expectations on earnings and gross margin, with EPS of $4.27 versus $4.22 expected. However, sales came in...

vor 4 Stunden · Moby

Lowe's Companies, Inc. Q2 2027 Earnings Call Summary

Moby summary of Lowe's Companies, Inc.'s Q2 2027 earnings call

vor 4 Stunden · GuruFocus.com

Lowe's Companies Inc (LOW) (Q2 2026) Earnings Call Highlights: Fifth Consecutive Quarter of ...

Lowe's navigates a challenging macro environment with disciplined execution, delivering $26 billion in revenue and raising its full-year outlook to the bottom end of prior guidance.

vor 5 Stunden · Investor's Business Daily

Stock Market Today: Dow Breaks Losing Streak As Moderna Catapults On Its Cancer Vaccine Win (Live Coverage)

Stock Market Today: The Dow Jones index rises Wednesday on Treasury buybacks. Moderna soars on cancer vaccine news.

Seite 1 von 2

Lowe's Companies Inc. (LOW)

Über LOW